BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28

• Business

  Aratana Therapeutics Adds Product Manufacturing Expertise with the Appointment of Two Senior Executives

  February 12, 2013

   · 

  2 min read
• Drug Development

  Recipharm AB Supplies Clinical Trial Material for FDA Approved Phase IIb Study Sponsored by PledPharma

  February 12, 2013

   · 

  2 min read
• Business

  Albany Molecular Research, Inc. (AMRI) Announces Fourth Quarter 2012 Adjusted EPS of $0.17

  February 12, 2013

   · 

  1 min read
• Business

  Cannabis Science Inc. Appoints Harold C. Smith, Ph.D., Professor in Biochemistry, Biophysics and Oncology and a Member of the Center for RNA Biology at the University of Rochester, School of Dentistry and Medicine, to the Company’s Scientific Advisory Boa

  February 12, 2013

   · 

  4 min read
• BioMidwest

  Cincinnati Children’s Hospital Medical Center Study Finds Lymphoid Leukemia’s Weak Spot

  February 12, 2013

   · 

  4 min read
• BioMidwest

  Sigma-Aldrich Corporation’s Sigma Life Science Business to Distribute Worldwide Olink Bioscience’s Protein Interaction Analysis Technology

  February 12, 2013

   · 

  6 min read
• Drug Development

  Ferring Pharmaceuticals to Highlight Phase 3 Data for Cervical Ripening Candidate at Society for Maternal-Fetal Medicine Annual Meeting

  February 12, 2013

   · 

  1 min read
• Bio NC

  Grant Awarded to Study Novel Therapies for Muco-Obstructive Diseases Includes Studies on Cempra Pharmaceuticals, Inc.'s Solithromycin (CEM-101) in a Cystic Fibrosis Anti-inflammatory Model

  February 12, 2013

   · 

  4 min read
• Business

  Qvanteq AG Closes Series B Financing Round of $4.3 Million to Obtain Clinical Proof of Concept and CE Mark

  February 12, 2013

   · 

  1 min read
• Lone Star Bio

  Galderma Laboratories’s Tri-Luma® Cream, Only FDA-Approved Treatment for Melasma, Now Available in Pharmacies

  February 12, 2013

   · 

  5 min read